The World Health Organization (WHO) has prequalified the first vaccine, MVA-BN, against mpox amid rising global cases, including in Pakistan. This approval aims to improve vaccine access in high-need areas, reducing transmission and containing outbreaks. WHO Director-General Dr. Tedros emphasized the urgency of scaling up procurement and distribution to ensure equitable access and prevent infections, particularly in Africa and affected regions.
